StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) stock

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)

Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%

Bicycle Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bicycle Therapeutics's price to sales ratio was 4.2× on Nov 11, 2026, against 18.3× a year earlier. Over the last 5 years it ranged from 4.2× to 132.3×, with a median of 29.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.2×−13.1
2025Dec 31, 202517.3×−8.9
2024Dec 31, 202426.2×−4.7
2023Dec 29, 202330.9×−27.5
2022Dec 30, 202258.4×−73.9
2021Dec 31, 2021132.3×+100.5
2020Dec 31, 202031.8×+14.2
2019Dec 31, 201917.6×–

More Bicycle Therapeutics figures

See a number that looks wrong?